Ulcerative colitis trials in Georgia

In Georgia 10 Also abroad 381

10 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Where
Tbilisi
Age
18 years and over
People
1,380 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06651281 · EU 2024-513533-20-00
Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Kutaisi, Marneuli, Tbilisi
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 1/2Taking people
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Where
Tbilisi
Age
18 years to 75 years
People
270 worldwide
Run by
Xencor, Inc.
See details and how to joinNCT06619990
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Kutaisi, Marneuli, Tbilisi
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Kutaisi, Tbilisi
Age
16 years to 80 years
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Phase 2Taking people
Confirmatory Clinical Study in Active Ulcerative Colitis
Where
Kutaisi, Tbilisi
Age
16 years and over
People
204 worldwide
Run by
MRM Health NV
See details and how to joinNCT07296315 · EU 2025-524682-24-00
Phase 2Taking people
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Batumi, Tbilisi
Age
18 years to 75 years
People
204 worldwide
Run by
Palisade Bio
See details and how to joinNCT07845487
Phase 1/2Taking people
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
Where
Tbilisi
Age
18 years to 75 years
People
100 worldwide
Run by
Mage Biologics
See details and how to joinNCT07374471 · EU 2025-524719-35-00
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Kutaisi, Tbilisi
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 2Taking people
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Where
Kutaisi, Marneuli, Tbilisi
Age
18 years to 80 years
People
140 worldwide
Run by
Mirador Therapeutics, Inc.
See details and how to joinNCT07113522